Akinobu Takaki

5.9k total citations · 1 hit paper
152 papers, 3.6k citations indexed

About

Akinobu Takaki is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Akinobu Takaki has authored 152 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 83 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Akinobu Takaki's work include Liver Disease Diagnosis and Treatment (68 papers), Liver Diseases and Immunity (32 papers) and Hepatitis C virus research (30 papers). Akinobu Takaki is often cited by papers focused on Liver Disease Diagnosis and Treatment (68 papers), Liver Diseases and Immunity (32 papers) and Hepatitis C virus research (30 papers). Akinobu Takaki collaborates with scholars based in Japan, United States and United Kingdom. Akinobu Takaki's co-authors include Kazuhide Yamamoto, Daisuke Kawai, Hidenori Shiraha, Yasuhiro Miyake, Fusao Ikeda, Kazuhiro Nouso, Tetsuya Yasunaka, Hiroyuki Okada, Haruhiko Kobashi and Shinichiro Nakamura and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Akinobu Takaki

139 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

2013 355 citations Akinobu Takaki, Daisuke Kawai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akinobu Takaki Japan	33	1.8k	1.8k	931	603	530	152	3.6k
Tadashi Namisaki Japan	29	1.5k 0.9×	1.2k 0.7×	952 1.0×	500 0.8×	384 0.7×	159	3.3k
Mitsuteru Kitade Japan	32	1.2k 0.7×	1.2k 0.7×	1.2k 1.3×	572 0.9×	527 1.0×	88	3.2k
Ryuichi Noguchi Japan	31	1.6k 0.9×	1.5k 0.8×	992 1.1×	454 0.8×	540 1.0×	98	3.8k
Alessandra Caligiuri Italy	35	1.8k 1.0×	2.0k 1.1×	878 0.9×	1.1k 1.9×	248 0.5×	48	3.9k
Toshihiko Mizuta Japan	33	2.1k 1.2×	1.4k 0.8×	867 0.9×	538 0.9×	358 0.7×	108	3.9k
Masaru Harada Japan	31	1.3k 0.7×	802 0.5×	1.1k 1.2×	655 1.1×	294 0.6×	198	4.0k
Francisco Javier Cubero Spain	32	1.3k 0.7×	793 0.5×	937 1.0×	404 0.7×	323 0.6×	90	2.9k
Eitaro Taniguchi Japan	27	1.1k 0.6×	1.2k 0.7×	832 0.9×	420 0.7×	341 0.6×	66	2.9k
Hironori Koga Japan	39	1.7k 1.0×	1.8k 1.0×	1.7k 1.8×	762 1.3×	611 1.2×	155	5.3k
Shuichi Seki Japan	28	1.4k 0.8×	1.3k 0.7×	942 1.0×	581 1.0×	214 0.4×	129	3.4k

Countries citing papers authored by Akinobu Takaki

Since Specialization

Citations

This map shows the geographic impact of Akinobu Takaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinobu Takaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinobu Takaki more than expected).

Fields of papers citing papers by Akinobu Takaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinobu Takaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinobu Takaki. The network helps show where Akinobu Takaki may publish in the future.

Co-authorship network of co-authors of Akinobu Takaki

This figure shows the co-authorship network connecting the top 25 collaborators of Akinobu Takaki. A scholar is included among the top collaborators of Akinobu Takaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinobu Takaki. Akinobu Takaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takaki, Akinobu, et al.. (2025). Cholecystectomy Is Linked to Worse Clinical Outcomes in Primary Sclerosing Cholangitis. Cureus. 17(3). e80184–e80184.

Takeuchi, Akihito, Masanori Abe, Sachiko Furukawa, et al.. (2025). Validation of PBC‐10 in Japanese patients with primary biliary cholangitis. Hepatology Research. 55(7). 986–993.

Kawano, Seiji, Akinobu Takaki, Yoshiyasu Kono, et al.. (2024). Relevance of oxidative stress for small intestinal injuries induced by nonsteroidal anti-inflammatory drugs: A multicenter prospective study. Medicine. 103(50). e40849–e40849. 1 indexed citations

Takeuchi, Yasuto, Kazuhiro Nouso, Shinichi Fujioka, et al.. (2023). The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab. Cancer Medicine. 12(17). 17559–17568. 3 indexed citations

Oyama, Atsushi, Akinobu Takaki, Takuya Adachi, et al.. (2023). Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan. Hepatology International. 17(5). 1215–1224. 1 indexed citations

Takaki, Akinobu, Yasuto Takeuchi, & Tetsuya Yasunaka. (2022). Primary biliary cholangitis : PBC. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 134(3). 180–184.

Ohira, Hiromasa, Atsushi Takahashi, Mikio Zeniya, et al.. (2022). Clinical practice guidelines for autoimmune hepatitis. Hepatology Research. 52(7). 571–585. 14 indexed citations

Takahashi, Atsushi, Hiromasa Ohira, Kazumichi Abe, et al.. (2020). Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Scientific Reports. 10(1). 14250–14250. 21 indexed citations

Shiraha, Hidenori, Daisuke Uchida, Masaya Iwamuro, et al.. (2019). A Phase I/Ib Trial of Ad-REIC in Liver Cancer: Study Protocol. Future Oncology. 15(31). 3547–3554. 9 indexed citations

10.

Takahashi, Atsushi, Kei Moriya, Hiromasa Ohira, et al.. (2018). Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey. PLoS ONE. 13(10). e0204772–e0204772. 23 indexed citations

11.

Kawano, Seiji, Akinobu Takaki, Masaya Iwamuro, et al.. (2017). Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation. BioMed Research International. 2017. 1–6.

12.

Shiraha, Hidenori, Shigeru Horiguchi, Daisuke Uchida, et al.. (2016). Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. Oncology Reports. 35(5). 2576–2582. 12 indexed citations

13.

Morimoto, Yuki, Kazuhiro Nouso, Nozomu Wada, et al.. (2014). Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma. Hepatology Research. 44(14). E353–9. 32 indexed citations

14.

Horiguchi, Shigeru, Hidenori Shiraha, Masaya Iwamuro, et al.. (2013). Loss of runt‐related transcription factor 3 induces gemcitabine resistance in pancreatic cancer. Molecular Oncology. 7(4). 840–849. 29 indexed citations

15.

Ikeda, Fusao, Nobuyuki Baba, Koichi Takaguchi, et al.. (2012). Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5‐year study of patients with hepatitis B with lamivudine resistance. Journal of Medical Virology. 84(10). 1562–1570. 3 indexed citations

16.

Takaki, Akinobu, Hidenori Shiraha, Kazuko Koike, et al.. (2011). Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients. BMC Cancer. 11(1). 458–458. 27 indexed citations

17.

Nakanishi, Yutaka, Hidenori Shiraha, Minoru Matsubara, et al.. (2011). Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer. 11(1). 3–3. 26 indexed citations

18.

Takaki, Akinobu, Hideyuki Suzuki, Yoshiaki Iwasaki, et al.. (2008). A 27-year-old man who died of acute liver failure probably due to trichloroethylene abuse. Journal of Gastroenterology. 43(3). 239–242. 8 indexed citations

19.

Miyake, Yasuhiro, Yoshiaki Iwasaki, Akinobu Takaki, et al.. (2007). Clinical Features of Japanese Elderly Patients with Type 1 Autoimmune Hepatitis. Internal Medicine. 46(24). 1945–1950. 26 indexed citations

20.

Ogawa, Shin, et al.. (2000). Increase in CD95 (Fas/APO‐1)‐positive CD4⁺ and CD8⁺ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena. Journal of Gastroenterology and Hepatology. 15(1). 69–75. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact